Campaigns

Persistent cough, chest pain, shortness of breath, and unexplained weight loss may indicate lung cancer.

Treatment includes radical cystectomy, chemotherapy, radiation therapy, and immunotherapy based on cancer stage and spread.

Unlocking the EGFR code helps personalize cancer treatment, improving outcomes through targeted therapy strategies.

NGS enables precise cancer treatment by decoding tumor genetics, driving the genomics revolution in oncology care.

Protecting heart health during cancer therapy prevents cardiotoxicity and ensures safer, more effective treatment outcomes.

Effective management combines chemotherapy, targeted therapy, and transplants for improved outcomes in hematological malignancies.

Immunotherapy empowers the immune system to target cancer cells, offering hope in advanced and resistant cancers.

Targeted liver therapies deliver precise treatment, minimizing damage and improving outcomes in liver cancer and metastases.

Lutetium-177 targets prostate cancer cells precisely, offering advanced treatment with improved survival and reduced side effects.

Modern lung cancer screening with low-dose CT scans enables early detection, improving treatment success and survival outcomes.

Molecular tumor boards guide personalized cancer therapy by integrating genomic data with expert multidisciplinary treatment planning.

Precision oncology tailors treatments in metastatic colorectal cancer using genetic profiling for more effective, personalized care outcomes.

Precision oncology enables personalized treatment in metastatic colorectal cancer using genetic profiling and targeted therapies.

Multidisciplinary teams unite expertise to improve ovarian cancer outcomes through personalized, collaborative, and comprehensive care.

Decoding cancer through precision oncology empowers personalized treatment using genetic insights and expert collaboration.

Advanced bladder cancer requires timely diagnosis and personalized treatment to improve survival and manage complications effectively.

Precision in cancer therapy targets specific mutations, maximizing treatment effectiveness while minimizing side effects.

Early lung cancer often shows no symptoms but is highly treatable when detected through early screening.

Early detection, targeted therapies, and genetic research are powerful forces advancing the fight against ovarian cancer.

Rewiring the immune system enhances the body’s ability to detect and destroy cancer cells more effectively.